← Eichor
Study identifier: NCT07486115 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People

Condition: Healthy  ·  Sponsor: Boehringer Ingelheim

PhasePhase 1
Planned participants136
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3814916 in healthy male and female trial participants.

This description comes directly from the study's public registry record.

Talk to the study team

Boehringer Ingelheim  ·  1-800-243-0127  ·  clintriage.rdg@boehringer-ingelheim.com

Always discuss trial participation with your own doctor first.

Locations (1)

SGS Life Science Services - Clinical ResearchEdegem, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07486115